Strs Ohio Buys 52,401 Shares of Corteva, Inc. $CTVA

Strs Ohio raised its stake in Corteva, Inc. (NYSE:CTVA) by 17.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 359,889 shares of the company’s stock after purchasing an additional 52,401 shares during the period. Strs Ohio owned 0.05% of Corteva worth $30,126,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. JPL Wealth Management LLC bought a new stake in shares of Corteva during the 3rd quarter worth about $25,000. Garton & Associates Financial Advisors LLC acquired a new position in Corteva in the 4th quarter valued at about $27,000. Bank of Jackson Hole Trust bought a new position in Corteva in the 4th quarter valued at about $28,000. Cornerstone Financial Management LLC bought a new position in Corteva in the 4th quarter valued at about $29,000. Finally, Basepoint Wealth LLC acquired a new stake in Corteva during the fourth quarter worth approximately $30,000. 81.54% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CTVA. Oppenheimer upped their target price on Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Royal Bank Of Canada lifted their price target on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. CICC Research boosted their price target on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Jefferies Financial Group upped their price objective on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Finally, Rothschild & Co Redburn increased their price objective on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average target price of $88.90.

Corteva Trading Down 0.2%

Shares of CTVA stock opened at $85.63 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The stock has a market cap of $57.27 billion, a P/E ratio of 50.37, a price-to-earnings-growth ratio of 2.62 and a beta of 0.56. The stock has a 50 day simple moving average of $79.80 and a 200 day simple moving average of $76.86. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.95.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the company earned $1.13 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.